Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiae202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Amit Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201, United States. Hauptthemen laut MEDLINE: Neutrophils, Bordetella pertussis, Whooping Cough, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, University of Maryland, NIH HHS.
Abstract (Originalsprache)
Interferon lambda plays diverse roles in bacterial infections. Previously, we showed that interferon lambda is induced in the lungs of Bordetella pertussis-infected adult mice and exacerbates inflammation. Here, we report that mice lacking the interferon lambda receptor 1 specifically on neutrophils (MRP8creIFNLR1fl/fl mice) exhibit reduced lung bacterial load and inflammation compared to wild-type mice during B. pertussis infection. In B. pertussis-infected wild-type mice, lung type I and III IFN responses were higher than in MRP8creIFNLR1fl/fl mice, correlating with increased lung inflammatory pathology. There was an increased proportion of interferon gamma-producing neutrophils in the lungs of MRP8creIFNLR1fl/fl mice compared to wild-type mice. IFNLR1−/− neutrophils incubated with B. pertussis exhibited higher killing compared to wild-type neutrophils. Treatment of wild-type neutrophils with interferon lambda further decreased their bacterial killing capacity and treatment of wild-type mice with interferon lambda increased lung bacterial loads. Contributing to the differential killing, we found that IFNLR1−/− neutrophils exhibit higher levels of reactive oxygen species, myeloperoxidase, matrix metalloproteinase-9 activity, neutrophil extracellular traps, and interferon gamma secretion than wild-type neutrophils, and inhibiting NADPH oxidase inhibited bacterial killing in IFNLR1−/− neutrophils. B. pertussis-induced interferon lambda secretion and IFNLR1 gene expression in mouse and human neutrophils and this was dependent on the bacterial virulence protein pertussis toxin. Pertussis toxin enhanced bacterial loads in wild type but not in MRP8creIFNLR1fl/fl or IFNLR1−/− mice. Thus, pertussis toxin disrupts neutrophil function by enhancing type III IFN signaling, which prevents neutrophils from effectively clearing B. pertussis during infection, leading to higher bacterial loads and exacerbation of lung inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201, United States.
- Department of Medicine, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States.
ORCID-Profile: Nicholas H Carbonetti
Förderung
- NIAID NIH HHS
- University of Maryland
- NIH HHS
- Baltimore Institute for Clinical and Translational Research
- NIH
Zitieren
APA
Kumar, A., Johnson, D., Bukowski, A., Noto, M. J., & Carbonetti, N. H. (2025). Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae202
Vancouver
Kumar A, Johnson D, Bukowski A, Noto MJ, Carbonetti NH. Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae202
BibTeX
@article{Kumar2025,
author = {Kumar, Amit and Johnson, Da'Kuawn and Bukowski, Alicia and Noto, Michael J and Carbonetti, Nicholas H},
title = {Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiae202}
}
EUVIMED